EyeStat
Commercial- Indications
- Traumatic brain injury, Concussion
Company intelligence / Profile preview
The EyeStat device has received FDA clearance to objectively measure and assess the blink reflex. Clinical studies have demonstrated its utility in detecting abnormal blink patterns associated with traumatic brain injury and monitoring progression of neurodegenerative diseases. The company emphasizes data-driven value from ongoing clinical trials and real-world use cases in sports medicine and neurology clinics.
No therapeutic drugs are being developed; focus remains on diagnostic accuracy.
Business model centers on both direct sales of devices to sports teams/clinics and monetization of collected clinical data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blinktbi.